Longboard Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2020
Revenue	1.8	1.8	2.5	-	14.38	6.27	Upgrade
Revenue Growth (YoY)	-28.00%	-28.00%	-	-	129.31%	-	Upgrade
Cost of Revenue	0.73	0.73	1.07	-	2.68	0.62	Upgrade
Gross Profit	1.07	1.07	1.43	-	11.7	5.66	Upgrade
Selling, General & Admin	1.12	1.09	2.67	6.79	5.71	1.9	Upgrade
Operating Expenses	1.12	1.09	2.67	6.79	5.71	1.9	Upgrade
Operating Income	-0.05	-0.02	-1.24	-6.79	5.99	3.75	Upgrade
Other Non Operating Income (Expenses)	423.26	43.19	4.39	-	0.3	0.08	Upgrade
EBT Excluding Unusual Items	423.21	43.17	3.15	-6.79	6.3	3.84	Upgrade
Gain (Loss) on Sale of Investments	-13.4	-13.4	-	-	-	-	Upgrade
Pretax Income	409.81	29.78	3.15	-6.79	6.3	3.84	Upgrade
Income Tax Expense	88.87	8.23	0.13	-	1.12	1.16	Upgrade
Earnings From Continuing Operations	320.94	21.54	3.02	-6.79	5.18	2.68	Upgrade
Earnings From Discontinued Operations	0.01	0.01	-12.95	-2.37	-	-	Upgrade
Net Income	320.95	21.55	-9.93	-9.16	5.18	2.68	Upgrade
Net Income to Common	320.95	21.55	-9.93	-9.16	5.18	2.68	Upgrade
Net Income Growth	6517.13%	-	-	-	93.48%	-	Upgrade
Shares Outstanding (Basic)	137	6	2	1	2	2	Upgrade
Shares Outstanding (Diluted)	137	6	2	1	2	2	Upgrade
Shares Change (YoY)	4039.81%	274.64%	27.75%	-26.91%	0.42%	1.31%	Upgrade
EPS (Basic)	2.34	3.73	-6.44	-7.59	3.13	1.63	Upgrade
EPS (Diluted)	2.34	3.73	-6.44	-7.59	3.13	1.63	Upgrade
EPS Growth	59.84%	-	-	-	92.67%	-	Upgrade
Free Cash Flow	-	-	20.21	-38.21	-4.17	1.16	Upgrade
Free Cash Flow Per Share	-	-	13.11	-31.66	-2.53	0.71	Upgrade
Gross Margin	59.44%	59.44%	57.16%	-	81.35%	90.18%	Upgrade
Operating Margin	-2.64%	-0.93%	-49.48%	-	41.68%	59.87%	Upgrade
Profit Margin	17830.29%	1197.20%	-397.02%	-	35.99%	42.65%	Upgrade
Free Cash Flow Margin	-	-	808.25%	-	-29.00%	18.53%	Upgrade
EBITDA	-	-	-0.97	-6.53	6.02	-	Upgrade
EBITDA Margin	-	-	-38.95%	-	41.84%	-	Upgrade
D&A For EBITDA	-	-	0.26	0.26	0.02	-	Upgrade
EBIT	-0.05	-0.02	-1.24	-6.79	5.99	3.75	Upgrade
EBIT Margin	-2.64%	-0.93%	-49.48%	-	41.68%	59.87%	Upgrade
Effective Tax Rate	21.69%	27.65%	4.14%	-	17.82%	30.29%	Upgrade
Revenue as Reported	-	-	-	-	14.38	6.27	Upgrade

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q